Sep 02, 09:07
100% of moneycontrol users recommend buying Vivimed Labs.
What's your call on Vivimed Labs today?
Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2995.60||0.48||3000.00||2286.80||51,025.56|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
IFGL Refractories Recommended on May 28th 2014
Recommended price 114.00 | Peak from reco 209.00 83.01%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Vivimed Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 521.36 crore.The company has reported a consolidated sales of Rs 366.54 crore and a Net Profit of Rs 17.13 crore for the quarter ended Jun 2014.
The company management includes Santosh Varalwar - Managing Director & CEO, V Manohar Rao - Whole Time Director, Subhash Varalwar - Whole Time Director, Sandeep Varalwar - Whole Time Director, S Raghunandan - Whole Time Director, P V Rathnam - Independent Director, M Bhagvanth Rao - Independent Director, Peesapati Venkateswarlu - Independent Director, Nixon Patel - Independent Director, Srinivas Chidambaram - Nominee Director.
It is listed on the BSE with a BSE Code of 532660 and the NSE with an NSE Code of VIVIMEDLAB.
Its Registered office is at Speciality Chemicals Division: Plot No.78-A,,Kolhar Industrial Area Bidar,Karnataka - 585403.
Their Registrars are Aarthi Consultants Pvt Ltd